WEE1 Inhibitor MK-1775, Docetaxel, and Cisplatin Before Surgery in Treating Patients With Borderline Resectable Stage III-IVB Squamous Cell Carcinoma of the Head and Neck
PHASE1
This phase I trial studies the side effects and the best dose of WEE1 inhib...
Status
Completed
Location
Fred Hutch/University of Washington Cancer Consortium
Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases.
PHASE1
This study is an open-label, exploratory, prospective clinical trial with d...
Status
Recruiting
Location
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology